Effect of acrolein on human alveolar macrophage NF-κB activity

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 277, Issue 3 21-3, 1999, Pages

  Li, Li ^a   Hamilton Jr , Raymond F ^a   Holian, Andrij ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Cytokine; I B; MG 132; Nuclear factor B

Indexed keywords

ACROLEIN; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; REGULATOR PROTEIN;

AIR POLLUTANT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LUNG ALVEOLUS MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0032886989     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.3.l550     Document Type: Article

References (41)

1. Agency for Toxic Substances and Disease Registry. Toxicological Profile for Acrolein. Atlanta, GA: Agency for Toxic Substances and Disease Registry, 1990. (Report 7P-90-01)
2. Aranyi, C., W. J. O'Shea, J. A. Graham, and F. J. Miller. The effects of inhalation of organic chemical air contaminants on murine lung host defenses. Fundam. Appl. Toxicol. 6: 713-720, 1986.
3. Astry, C. L., and G. J. Jakab. The effects of acrolein exposure on pulmonary antibacterial defenses. Toxicol. Appl. Pharmacol. 67: 49-54, 1983.
4. Baeuerle, P. A., and D. Baltimore. NF-kappa B: ten years after. Cell 87: 13-20, 1996.
5. Baeuerle, P. A., and T. Henkel. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12: 141-179, 1994.
6. Baldwin, A. S., Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14: 649-683, 1996.
7. Beg, A. A., and D. Baltimore. An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science 274: 782-784, 1996.
8. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-kappa B. Nature 376: 167-170, 1995.
9. Blackwell, T. S., and J. W. Christman. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell Mol. Biol. 17: 3-9, 1997.
10. Bours, V., G. Franzoso, K. Brown, S. Park, V. Azarenko, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. Lymphocyte activation and the family of NF-kappa B transcription factor complexes. Curr. Top. Microbiol. Immunol. 182: 411-420, 1992.
11. Caldwell, J. C., T. J. Woodruff, R. Morello-Frosch, and D. A. Axelrad. Application of health information to hazardous air pollutants modeled in EPA's cumulative exposure project. Toxicol. Ind. Health 14: 429-454, 1998.
12. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 9: 1586-1597, 1995.
13. Dauber, J. H., M. D. Rossman, and R. P. Daniele. Bronchoalveolar cell populations in acute sarcoidosis. Observations in smoking and nonsmoking patients. J. Lab. Clin. Med. 94: 862-871, 1979.
14. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Res. 11: 1475-1489, 1983.
15. Fels, A. O., and Z. A. Cohn. The alveolar macrophage. J. Appl. Physiol. 60: 353-369, 1986.
16. Green, G. M. Mechanisms of tobacco smoke toxicity on pulmonary macrophage cells. Eur. J. Respir. Dis. Suppl. 139: 82-85, 1985.
17. Green, G. M., G. J. Jakab, R. B. Low, and G. S. Davis. Defense mechanisms of the respiratory membrane. Am. Rev. Respir. Dis. 115: 479-514, 1977.
18. Grilli, M., J. J. Chiu, and M. J. Lenardo. NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143: 1-62, 1993.
19. Grundfest, C. C., J. Chang, and D. Newcombe. Acrolein: a potent modulator of lung macrophage arachidonic acid metabolism. Biochim. Biophys. Acta 713: 149-159, 1982.
20. Hamilton, R. F., Jr., M. E. Hazbun, C. A. Jumper, W. L. Eschenbacher, and A. Holian. 4-Hydroxynonenal mimics ozone-induced modulation of macrophage function ex vivo. Am. J. Respir. Cell Mol. Biol. 15: 275-282, 1996.
21. Holian, A. Inflammatory cells of the lung: macrophages. In: Comprehensive Toxicology, edited by I. G. Sipes, C. A. McQueen, and A. J. Gandolfi. New York: Elsevier Science, 1997, p. 115-131.
22. Jakab, G. J. Adverse effect of a cigarette smoke component, acrolein, on pulmonary antibacterial defenses and on viral-bacterial interactions in the lung. Am. Rev. Respir. Dis. 115: 33-38, 1977.
23. Jongeneel, C. V. Regulation of the TNF alpha gene. Prog. Clin. Biol. Res. 388: 367-381, 1994.
24. Leffingwell, C. M., and R. B. Low. Cigarette smoke components and alveolar macrophage protein synthesis. Arch. Environ. Health 34: 97-102, 1979.
25. Li, L., R. F. Hamilton, Jr., A. Kirichenko, and A. Holian. 4-Hydroxynonenal-induced cell death in murine alveolar macrophages. Toxicol. Appl. Pharmacol. 139: 135-143, 1996.
26. Li, L., R. F. Hamilton, Jr., D. E. Taylor, and A. Holian. Acrolein-induced cell death in human alveolar macrophages. Toxicol. Appl. Pharmacol. 145: 331-339, 1997.
27. Lin, Y. Z., S. Y. Yao, R. A. Veach, T. R. Torgerson, and J. Hawiger. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270: 14255-14258, 1995.
28. Low, E. S., R. B. Low, and G. M. Green. Correlated effects of cigarette smoke components on alveolar macrophage adenosine triphosphatase activity and phagocytosis. Am. Rev. Respir. Dis. 115: 963-970, 1977.
29. Maniatis, T. Catalysis by a multiprotein IkappaB kinase complex. Science 278: 818-819, 1997.
30. 2+, NF-κB binding, and transcription of the TNF-α gene in marine macrophages. J. Leukoc. Biol. 60: 784-792, 1996.
31. Muller, J. M., H. W. Ziegler-Heitbrock, and P. A. Baeuerle. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187: 233-256, 1993.
32. Palombella, V. J., O. J. Rando, A. L. Goldberg, and T. Maniatis. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78: 773-785, 1994.
33. Scheule, R. K., R. C. Perkins, R. Hamilton, and A. Holian. Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am. J. Physiol. 262 (Lung Cell. Mol. Physiol. 6): L386-L391, 1992.
34. Sha, W. C., H. C. Liou, E. I. Tuomanen, and D. Baltimore. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell 80: 321-330, 1995.
35. Sherwood, R. L., C. L. Leach, N. S. Hatoum, and C. Aranyi. Effects of acrolein on macrophage functions in rats. Toxicol. Lett. 32: 41-49, 1986.
36. Siebenlist, U., G. Franzoso, and K. Brown. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10: 405-455, 1994.
37. Stancovski, I., and D. Baltimore. NF-kappaB activation: the I kappaB kinase revealed? Cell 91: 299-302, 1997.
38. Thanos, D., and T. Maniatis. NF-kappa B: a lesson in family values. Cell 80: 529-532, 1995.
39. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274: 787-789, 1996.
40. Wang, C. Y., M. W. Mayo, and A. S. Baldwin, Jr. TNF and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 274: 784-787, 1996.
41. World Health Organization. Environmental health criteria. In: Acrolein. Geneva: World Health Organization, 1991. (Publ. 127)